Skip to main content
. Author manuscript; available in PMC: 2018 Jul 24.
Published in final edited form as: J Clin Oncol. 2014 Nov 3;33(3):244–250. doi: 10.1200/JCO.2014.56.2728

Table 4.

Any-Grade AEs Reported in > 15% of Patients Overall or Grade ≥ 3 AEs Reported in > 5% of Patients Overall

Ovarian (n = 193) Breast (n = 62) Pancreas (n = 23) Prostate (n = 8) Other (n = 12) Total (N = 298)






Any
Grade
Grade
≥ 3
Any
Grade
Grade
≥ 3
Any
Grade
Grade
≥ 3
Any
Grade
Grade
≥ 3
Any Grade Grade
≥ 3
Any
Grade
Grade
≥ 3












AE No. % No. % No. % No. % No. % No. % No. % No. % No. % No. % No. % No. %
Fatigue 116 60.1 12 6.2 30 48.4 3 4.8 17 73.9 3 13.0 1 12.5 0 0.0 12 100.0 1 8.3 176 59.1 19 6.4

Nausea 119 61.7 1 0.5 33 53.2 0 0.0 11 47.8 0 0.0 3 37.5 0 0.0 10 83.3 0 0.0 176 59.1 1 0.3

Vomiting 75 38.9 5 2.6 21 33.9 1 1.6 9 39.1 1 4.3 0 0.0 0 0.0 6 50.0 0 0.0 111 37.2 7 2.3

Anemia 62 32.1 36 18.7 16 25.8 9 14.5 9 39.1 4 17.4 5 62.5 1 12.5 6 50.0 2 16.7 98 32.9 52 17.4

Diarrhea 56 29.0 3 1.6 11 17.7 1 1.6 7 30.4 0 0.0 3 37.5 0 0.0 4 33.3 0 0.0 81 27.2 4 1.3

Abdominal pain 58 30.1 14 7.3 5 8.1 1 1.6 7 30.4 1 4.3 0 0.0 0 0.0 7 58.3 1 8.3 77 25.8 17 5.7

Decreased appetite 36 18.7 1 0.5 17 27.4 0 0.0 4 17.4 0 0.0 2 25.0 0 0.0 3 25.0 0 0.0 62 20.8 1 0.3

Dyspepsia 38 19.7 0 0.0 9 14.5 0 0.0 2 8.7 0 0.0 0 0.0 0 0.0 3 25.0 0 0.0 52 17.4 0 0.0

Headache 32 16.6 0 0.0 14 22.6 1 1.6 1 4.3 0 0.0 0 0.0 0 0.0 1 8.3 0 0.0 48 16.1 1 0.3

Dysgeusia 39 20.2 0 0.0 4 6.5 0 0.0 1 4.3 0 0.0 0 0.0 0 0.0 3 25.0 0 0.0 47 15.8 0 0.0

Abbreviation: AE, adverse event.